Killian Meara

The findings underscore the connection between COVID-19 and the increased risk from obesity.

Cells reactive to SARS-CoV-2 peptide pools were found in all anti-NP IgG–positive individuals.

Novel positive controls offer several advantages over the ones currently used in COVID-19 testing.

SARS-CoV-2 infects cardiomyocytes through an ACE2 and endosomal inflammatory infiltrate.

The committee encourages those eligible to receive the vaccine when available to them.

SARS-CoV-2 infection is known to result in a number of extrapulmonary manifestations.

Prime Minister Narendra Modi of India receives vaccine as country begins next phase of program.

The VRBPAC voted 22-0 with no abstentions to support the benefit-risk profile associated with Ad26.COV2.S on Friday night.

Vitamin B6 is a water-soluble vitamin found in various foods such as fish, whole grains, and bananas.

Patients with cardiometabolic conditions have a high risk of poor outcomes.

The country has no domestic production, and the government has been accused of not acquiring doses quickly enough.

Multiple observational and ex-vivo laboratory studies have demonstrated that IL-6 is an important cytokine associated with disease severity and mortality.

If approved, the decision could have a significant impact on the mass vaccination programs.

Pooled testing allows multiple samples to be processed at once and help increase testing efficiency.

Not every positive patient missed by PCR and antigen tests will be infectious to others.

The data supports strong guidance for enhanced precautions to prevent SARS‐CoV‐2 infection in pregnancy.

SAP1 and SAP6 were found to inhibit a SARS-CoV-2 infection.

Understanding underlying immunological mechanisms can provide critical insights.

Mediterranean region imposes partial lockdown following a surge in cases.

Immune memory is the basis for durable protective immunity after infections or vaccinations.

The session was part of the COVID-19 Real Time Learning Network.

The interval between doses can be safely extended to 3 months given the protection a single dose offers.

Findings may be valuable in situations where there is a limited testing capacity.

Findings indicate potential ways to identify individuals at higher or lower risk.

Study pinpoints the protein RIPK1 as a promising target for SARS-CoV-2 treatment.

The study was the first randomized clinical trial using the therapy to treat POTS.

Evaluating the impact of the SARS-CoV-2 virus on hospitalized patients.

The PCR diagnostic joins the company’s host of other SARS-CoV-2 research solutions.

Case numbers trend downward in Germany as UK implements new border policies.

Detailed analysis of SARS-CoV-2 showed predominant infection of human lung epithelial cells.